Paper4100152
R Factors in Escherichia coli in faeces after oral chemotherapy in general practice.
Datta N and 5 others. Lancet, 1971. Cited by 133 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. R Factors in Escherichia coli in faeces after oral chemotherapy in general practice. Papers, record 4100152. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4100152
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Administration, Oral | |
| Ampicillin | |
| Antigens | |
| Humans |
Source PubMed
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 133 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 29,076,047 | Tetracycline use in the community may promote decreased susceptibility to quinolones in Escherichia coli isolates. | Eur J Clin Microbiol Infect Dis | 2018 | https://conductscience.org/library/papers/29076047 | PubMed |
| 26,507,147 | Extended-spectrum β-lactamase-producing Enterobacteriaceae among pregnant women in Norway: prevalence and maternal-neonatal transmission. | J Perinatol | 2015 | https://conductscience.org/library/papers/26507147 | PubMed |
| 23,508,293 | Foodborne urinary tract infections: a new paradigm for antimicrobial-resistant foodborne illness. | Front Microbiol | 2013 | https://conductscience.org/library/papers/23508293 | PubMed |
| 20,939,612 | Synergy of nitric oxide and silver sulfadiazine against gram-negative, gram-positive, and antibiotic-resistant pathogens. | Mol Pharm | 2010 | https://conductscience.org/library/papers/20939612 | PubMed |
| 20,400,569 | Antibiotic resistance characteristics of environmental bacteria from an oxytetracycline production wastewater treatment plant and the receiving river. | Appl Environ Microbiol | 2010 | https://conductscience.org/library/papers/20400569 | PubMed |
| 15,577,930 | Antibacterial resistance worldwide: causes, challenges and responses. | Nat Med | 2004 | https://conductscience.org/library/papers/15577930 | PubMed |
| 8,891,151 | Problem of antimicrobial resistance of fecal aerobic gram-negative bacilli in the elderly. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8891151 | PubMed |
| 6,995,336 | Comparative analysis of plasmids and some metabolic characteristics of Escherichia coli K1 from diseased and healthy individuals. | Infect Immun | 1980 | https://conductscience.org/library/papers/6995336 | PubMed |
| 6,972,732 | Comparative efficacy and safety of nalidixic acid versus trimethoprim/sulfamethoxazole in treatment of acute urinary tract infections in college-age women. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/6972732 | PubMed |
| 6,363,527 | Resistance of Escherichia coli in faeces and the use of antimicrobial agents in the treatment of hospital patients. | J Hyg (Lond) | 1983 | https://conductscience.org/library/papers/6363527 | PubMed |
| 6,305,648 | Pharmacokinetics of multiple doses of ceftizoxime and their influence on fecal flora. | Eur J Clin Microbiol | 1983 | https://conductscience.org/library/papers/6305648 | PubMed |
| 4,943,278 | Characteristics of antimicrobial resistance of Escherichia coli from animals: relationship to veterinary and management uses of antimicrobial agents. | Appl Microbiol | 1971 | https://conductscience.org/library/papers/4943278 | PubMed |
| 4,615,632 | Characterization and prevalence of the different mechanisms of resistance to beta-lactam antibiotics in clinical isolates of Escherichia coli. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/4615632 | PubMed |
| 4,598,847 | Effect of oral tetracycline on the occurrence of tetracycline-resistant strains of Escherichia coli in the intestinal tract of humans. | Antimicrob Agents Chemother | 1973 | https://conductscience.org/library/papers/4598847 | PubMed |
| 4,598,614 | Transferable antibiotic resistance in enteropathogenic Escherichia coli between 1948 and 1968. | Antimicrob Agents Chemother | 1973 | https://conductscience.org/library/papers/4598614 | PubMed |
| 4,597,729 | Interbacterial transfer of R factor in humans. | Antimicrob Agents Chemother | 1973 | https://conductscience.org/library/papers/4597729 | PubMed |
| 4,563,592 | Sulphadimidine, co-trimoxazole, and a placebo in the management of symptomatic urinary tract infection in general practice. | J R Coll Gen Pract | 1972 | https://conductscience.org/library/papers/4563592 | PubMed |
| 4,558,896 | Infectious diseases: annual review of significant publications. | Postgrad Med J | 1972 | https://conductscience.org/library/papers/4558896 | PubMed |
| 4,552,466 | Trimethoprim resistance determined by R factors. | Br Med J | 1972 | https://conductscience.org/library/papers/4552466 | PubMed |
| 4,552,258 | Antibiotic resistance and transmissible R-factors in the intestinal coliform flora of healthy adults and children in an urban and a rural community. | J Hyg (Lond) | 1972 | https://conductscience.org/library/papers/4552258 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4100152
GET https://conductscience.org/api/papers/v1/4100152/cited_by?page=2